CROWN ADVISORS MANAGEMENT, INC. Recursion Pharmaceuticals, Inc. Transaction History

CROWN ADVISORS MANAGEMENT, INC. portfolio value:

$319,000
portfolio value

Recursion Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 30K shares 319K $10.64 30K